Taro Provides Results for December 31, 2015

Go back to Taro Provides Results for December 31, 2015

Taro Pharma (TARO) Reports Q3 EPS of $4.41

February 10, 2016 5:16 PM EST

Taro Pharma (NYSE: TARO) reported Q3 EPS of $4.41, versus $3.33 reported last year. Revenue for the quarter came in at $258.3 million, versus $237.7 million reported last year.

For earnings history and earnings-related data on Taro Pharma (TARO) click here.

... More